Blood transfusion and infection after colorectal cancer surgery

Transfusion

Volumn 36, Issue 11-12, 1996, Pages 1000-1008

  Vamvakas, E C ^a,b   Carven, J H ^b   Hibberd, P L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHRONIC DISEASE; COLORECTAL CANCER; COLORECTAL SURGERY; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POSTOPERATIVE INFECTION; RISK FACTOR; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE CATHETER; WOUND INFECTION;

EID: 0029844960     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36111297091746.x     Document Type: Article

References (50)

1. Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990;30:651-8.
2. Francis DM. Relationship between blood transfusion and tumor behavior. Br J Surg 1991;78:1420-8.
3. Tartter PI. Blood transfusion and bacterial infections: clinical studies. In: Singal DP, ed. Immunological effects of blood transfusion. Boca Raton, FL: CRC Press, 1994:111-26.
4. Bordin JO, Meddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
5. Klein HO. Immunomodulation caused by blood transfusion. In: Petz LD, Swisher SN, Kleinman S, et al, eds. Clinical practice of transfusion medicine. New York: Churchill Livingstone, 1996:59-69.
6. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-6.
7. Houbiers JG, Brand A, van de Watering LM, et al. Randomized controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573-8.
8. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-67.
9. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
10. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-33.
11. Busch OR, Hop WC, Marquet RL, Jeekel J. Autologous blood and infections after colorectal surgery (letter). Lancet 1994;343:668-9.
12. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized controlled clinical trials. Transfusion 1996;36:175-86.
13. Vamvakas EC, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993;33:754-65.
14. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995;35:760-8.
15. Vamvakas E, Moore SB. Blood transfusion and postoperative septic complications. Transfusion 1994;34:714-27.
16. Ford CD, Vanmoorleghem G, Menlove RL. Blood transfusions and postoperative wound infection. Surgery 1993;113:603-7.
17. Meares EM Jr. Current patterns in nosocomial urinary tract infections. Urology 1991;37(3Suppl):9-12.
18. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994;161:374-8.
19. Skerrett SJ, Niederman MS, Fein AM. Respiratory infections and acute lung injury in systemic illness. Clin Chest Med 1989;10:469-502.
20. Hanson LC, Weber DJ, Rutala WA. Risk factors for nosocomial pneumonia in the elderly. Am J Med 1992;92:161-6.
21. Sawyer RG, Pruett TL. Wound infections. Surg Clin North Am 1994;74:519-36.
22. Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133:792-6.
23. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987;317:1376-82.
24. Tryba M. The gastropulmonary route of infection - fact or fiction? Am J Med 1991;91(2A):135S-146S.
25. McFarland LV. Diarrhea acquired in the hospital. Gastroenterol Clin North Am 1993;22:563-77.
26. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987:30-53.
27. Miettinen O. Confounding and effect-modification. Am J Epidemiol 1974;100:350-3.
28. Jahnson S, Andersson M. Adverse effects of perioperative blood transfusion in patients with colorectal cancer. Eur J Surg 1992;158:419-25.
29. Tartter PI, Driefuss RM, Malon AM, et al. Relationship of postoperative septic complications and blood transfusions in patients with Crohn's disease. Am J Surg 1988;155:43-8.
30. Wobbes T, Bemelmans BL, Kuypers JH, et al. Risk of postoperative septic complications after abdominal surgical treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet 1990;171:59-62.
31. Pinto V, Baldonedo R, Nicolas C, et al. Relationship of transfusion and infectious complications after gastric carcinoma operations. Transfusion 1991;31:114-8.
32. Jensen LS, Andersen A, Fristrup SC, et al. Comparison of one dose versus three doses of prophylactic antibiotics, and the influence of blood transfusion, on infectious complications in acute and elective colorectal surgery. Br J Surg 1990;77:513-8.
33. Vamvakas E, Moore SB, Cabanela M. Blood transfusion and septic complications after hip replacement surgery. Transfusion 1995;35:150-6.
34. Blumberg N, Heal JM, Murphy P, et al. Association between transfusion of whole blood and recurrence of cancer. Br Med J (Clin Res Ed) 1986;293:530-3.
35. Marsh J, Donnan PT, Hamer-Hodges DW. Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg 1990;77:623-6.
36. Teitel JM, Freedman JJ, Garvey MB, Kardish M. Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1. Am J Hematol 1989;32:262-72.
37. Cuthbert RJ, Ludlam CA, Steel CM, et al. Immunological studies in HIV seronegative hemophiliacs: relationships to blood product therapy. Br J Haematol 1992;80:364-9.
38. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance System (NNIS) Information Packet. Atlanta, GA: US Department of Health and Human Services, 1994.
39. Charlson ME, Pomper P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
40. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988;75:789-92.
41. Braga M, Vignali A, Radaelli G, et al. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992;158:531-6.
42. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982:227-90.
43. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd ed. St. Louis, MO: Mosby, 1996.
44. Fernandez MC, Gottlieb M, Menitove JE. Blood transfusion and postoperative infection in orthopedic patients. Transfusion 1992;32:318-22.
45. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-9.
46. Blumberg N, Heal JM. Transfusion and the immune system: a paradigm shift in progress? (commentary). Transfusion 1995;35:879-83.
47. Jensen LS, Grunnet N, Hanberg-Sorensen F, Jorgensen J. Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion 1995;35:719-22.
48. Blumberg N, Heal JM. Blood transfusions and prognosis in colorectal cancer (letter). N Engl J Med 1993;329:1355.
49. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy: I. Medical. Stat Med 1989;8:441-54.
50. Miller JN, Colditz GA, Mosteller F. How study design affects outcomes in comparisons of therapy: II. Surgical. Stat Med 1989;8:455-66.